ArticleBMC cancer2026
Stromal hypoxia and autophagy signatures as indicators of pathologic response in triple-negative breast cancer.
Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTriple-negative breast cancer (TNBC) is an aggressive subtype with limited therapeutic targets. Hypoxia, autophagy, apoptosis, and translational stress are key biological processes involved in tumor progression and treatment resistance, but their predictive value for neoadjuvant chemotherapy (NACT) response remains unclear. This study aimed to investigate the association of hypoxia-related (HIF-1α), autophagy-related (Beclin-1, LC3A), apoptosis-related (Bcl-2), and translational stress–related (eIF2α) markers with response to NACT in TNBC, and to explore their relationships with clinicopathological features and survival outcomes.
methodsFifty-seven patients with TNBC who received NACT were retrospectively analyzed. Pretreatment tru-cut biopsy specimens were immunohistochemically stained for HIF-1α, Beclin-1, LC3A, Bcl-2, and eIF2α. Marker expression was evaluated using two semi-quantitative scoring systems. Pathological response was assessed using the Miller–Payne (MP) system and Residual Cancer Burden (RCB) classification. Associations with clinicopathological parameters, Miller–Payne (MP) and Residual Cancer Burden (RCB) systems, post-NACT morphological features, and survival were assessed using Spearman correlation, Kruskal–Wallis test, ROC analysis, chi-square tests, and Kaplan–Meier survival.
resultsBeclin-1 expression was significantly associated with higher MP response (p = 0.019) and demonstrated meaningful discriminatory ability for predicting good response (p = 0.02). HIF-1α showed a weak positive correlation with MP score (p = 0.042) and a borderline predictive trend (p = 0.078). LC3A, Bcl-2, and eIF2α did not show significant predictive value for treatment response. Stromal HIF-1α expression was significantly associated with increased stromal lymphocytic infiltration (p = 0.009), reduced residual invasive tumor following NACT (p = 0.039), and increased foamy/hemosiderin-laden macrophages (p = 0.020–0.039), indicating hypoxia-related stromal remodeling. None of the biomarkers predicted overall or disease-free survival, whereas high MP response and RCB 0–1 were strong predictors of favorable outcomes.
conclusionsBeclin-1 and stromal HIF-1α may serve as useful predictors of pathological response to NACT in TNBC, reflecting the biological impact of autophagy activation and hypoxia-mediated stromal modulation. Incorporation of these markers into pretreatment evaluation may improve response stratification in TNBC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.